Evidence map›Paper›PMID 25620957›Full record

ReviewFrontiers in microbiology2014

Endophytic fungi: a reservoir of antibacterials.

Sunil K Deshmukh, Shilpa A Verekar, Sarita V Bhave

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 205 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. The endophytic fungusCurrent research in microbial sciences · 2025
    Article
  6. Identification and genome insights intoFrontiers in plant science · 2025
    Article
  7. Endophytic Fungus UJ3-2 fromMolecules (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Isolation of the Endophytic FungusPlants (Basel, Switzerland) · 2024
    Article
  10. Review
  11. Review
  12. Article
  13. Endophytic fungi ofSaudi journal of biological sciences · 2024
    Article
  14. Article
  15. Frontiers in microbiology · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sunil K DeshmukhDepartment of Natural Products, Piramal Enterprises Limited Mumbai, India.
Shilpa A VerekarDepartment of Natural Products, Piramal Enterprises Limited Mumbai, India.
Sarita V BhaveDepartment of Natural Products, Piramal Enterprises Limited Mumbai, India.
Piramal (India) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug drug resistant bacteria are becoming increasingly problematic particularly in the under developed countries of the world. The most important microorganisms that have seen a geometric rise in numbers are Methicillin resistant Staphylococcus aureus, Vancomycin resistant Enterococcus faecium, Penicillin resistant Streptococcus pneumonia and multiple drug resistant tubercule bacteria to name a just few. New drug scaffolds are essential to tackle this every increasing problem. These scaffolds can be sourced from nature itself. Endophytic fungi are an important reservoir of therapeutically active compounds. This review attempts to present some data relevant to the problem. New, very specific and effective antibiotics are needed but also at an affordable price! A Herculean task for researchers all over the world! In the Asian subcontinent indigenous therapeutics that has been practiced over the centuries such as Ayurveda have been effective as "handed down data" in family generations. May need a second, third and more "in-depth investigations?"

Indexed as

antibacterial compoundsdrug resistanceendophytic fungimedicinal plantsnatural products

Identifiers

PMID25620957
PMCPMC4288058
OpenAlexW1996973963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.